The ISN is deeply saddened to learn of the sudden passing of Jan Weening.
Dr. Weening served as ISN secretary-general in the late nineties and president of the ISN from 2003 to 2005; he was the first pathologist to serve in this role.
Dr. Weening focused his leadership on increasing support for investment in science and education and making the most effective use of scarce resources to address the kidney disease epidemic. He also emphasized the need to work toward a fair and safe world where good health care and education are accessible to all.
Dr. Weening made significant contributions in pathology and nephrology. Scientifically he focused on glomerulonephritis and led the process of convening the group to revise the WHO lupus nephritis classification to create the ISN/RPS lupus nephritis classification.
In harmony with his wishes, Dr. Weening donated his kidneys for transplantation.
The ISN offers sincere condolences to Dr. Weening's family, colleagues, and friends.
Nominated by ISN members and selected by the ISN Awards Committee and Lillian Jean Kaplan Prize Advisory Committee, the ISN is pleased to announce the deserved 2022 awardees, honored for their commitment to kidney care:
Dr. Ananth Karumanchi: Winner of the Jean Hamburger Award
Dr. Hamid Rabb: Winner of the Bywaters Award
Dr. Alessandra Boletta and Dr. Albert Ong: Winners of the Lillian Jean Kaplan International Prize
The Lillian Jean Kaplan 2022 prize winners will present scientific talks at the WCN'22 Lillian Jean Kaplan Prize session on Sunday, February 27, 2022, 12:30-1:30 a.m. MYT (Saturday, February 26, 2022, 5.30-6.30 p.m. CET).
Is Your ISN Membership Profile Up-to-Date? Stay Connected
When you have an up-to-date ISN membership profile, your colleagues in the international nephrology community can easily find you in the online directory on the membership portal, not only by name and country but also through shared interests and specialty areas. This is especially useful as your network throughout the year and at WCN'22 next month.
The ISN invites all its members to complete their membership profiles.
Members who complete all sections of their profile by the end of February will automatically be entered into a raffle with the chance of winning one of five free annual memberships for one year!*
In addition to the full scientific program taking place virtually, the Malaysian kidney care community will be able to attend in-person sessions and activities. All content will be broadcast on the virtual platform and available on-demand.
Join this global community for an outstanding program, the chance to renew and forge new associations, and contribute to the worldwide advancement of kidney care.
Look out for the latest pre-congress newsletter in your inbox next week, featuring sneak previews of prominent WCN’22 speakers outlining a compelling range of scientific topics:
Brenda Hemmelgarn on shared decision-making to treat chronic kidney disease
Lydia Kamaruzaman on improving kidney function testing
Frances Mortimer on sustainable kidney care
Kar Hui Ng on the genetic causes of kidney disease in Asia
Katalin Susztak on genetic markers for inflammation and fibrosis in kidney disease
Esther Tan on setting up urgent-start peritoneal dialysis programs
The newsletter will also feature sections on how to best maximize WCN’22 platform features, along with updates on industry symposia, social media, advocacy, and young nephrologist activities taking place during the congress.
Get to Know a Selection of WCN'22 Speakers Through a Series of Video Interviews
Watch the WCN'22 speaker video interviews to find out why these health care practitioners chose their professions and get a sneak preview of the topics they will present at the congress.
From a game-changing service providing nocturnal hemodialysis in a home-training dialysis unit in Australia to international workshops benefitting young people living with Alport Syndrome in the UK, these films present the challenging realities facing kidney disease patients.
Touching, motivating, and sometimes surprising, these films all have the power to improve the lives of patients worldwide as they help raise awareness of kidney health issues.
Which of these seven films will win the “2022 ISN Film Community Best Film”? Your vote will help decide the outcome!
One Week Remaining to Share Your Work at the ISN Frontiers Meeting in Bergamo, Italy: Submit an Abstract Before February 16
The ISN Frontiers Meeting, ‘Complement-related kidney diseases: classification, genetics, and treatment,' offers researchers a rare opportunity to showcase their work on this specialty topic and raise their profile in the field.
Share and present your research to clinicians, scientists, academics, and general practitioners from around the world.
Accepted abstracts will be presented as posters and published in Kidney International Reports. A limited number of abstracts will be selected for oral presentations at the ISN Frontiers Meeting in Bergamo.
The deadline for abstract submissions and travel grant applications is February 16, 2022.
Find more information on this ISN Frontiers meeting here.
The ISN Welcomes Six Newly-Formed Partnerships into the ISN Sister Renal Centers Program
The SRC Committee is pleased to announce that six new partnerships have been accepted into the Sister Renal Centers (SRC) Program. The partnerships were selected based on the potential to support the emerging center to become a center of reference for kidney health in the region.
In addition, the ISN is happy to report that three partnerships have successfully graduated from the SRC Program, having completed all three levels of the program over six years of collaboration.
Please join us in congratulating these SRC pairs for establishing robust kidney care services in low-resource regions despite significant pandemic-related challenges during the collaboration.
Meet Hamze Ibrahim Rage, the 2022 Detlef Schlöndorff ISN Fellow
The ISN congratulates and welcomes Hamze Ibrahim Rage, this year’s Detlef Schlöndorff ISN Fellowship recipient. His training is supported by the Detlef Schlöndorff Fellowship Fund.
Hamze, from Hargeisa Group Hospital in Somalia, will train at the University of Cape Town Groote Schuur Hospital in South Africa, an ISN Regional Training Center. When he returns to Somalia after training, he will be one of the first nephrologists in the country, where he hopes to set up peritoneal dialysis and kidney biopsy services.
The research for the paper was led by Marcello Tonelli, iNET-CKD, i3C, and ISN-ACT Networks member. Aiming to support chronic kidney disease (CKD) advocacy efforts, this cohort study compares the clinical consequences associated with severe CKD to those associated with cancer.
The findings demonstrate that the risk of mortality and other outcomes for CKD are comparable to those for patients with non-metastatic cancer, highlighting the importance of CKD as a public health issue.
“Are Your Kidneys Healthy?” Quiz Now Available in 12 Languages, Including Amharic
Almost 60, 000 people have taken the ISN “Are Your Kidneys Healthy?” quiz since it launched less than a year ago.
Take the quiz to find out if your kidneys are healthy.
Last week the quiz was added in Amharic, alongside the already available Arabic, Chinese, English, French, German, Hindi, Italian, Japanese, Portuguese, Russian, and Spanish, increasing the number of languages to 12.
This year, the ISN hopes to reach even more people by including additional languages - look out for Slovenian and Bengali versions coming soon! If you'd like to add your language to the quiz site, please contact Monica Moorthy at firstname.lastname@example.org.
Do You Follow the Monthly ISN-ACT Global Trials Focus List? Discover it Now and Welcome Its New Leadership
Interest in the GTF is constantly increasing, prompting exchange and discussions on recent developments in kidney health research. Under Brendan Smyth's leadership as GTF coordinator, the initiative expanded to provide young nephrologists with the chance to collaborate on each edition. Clinical trials are now highlighted in additional languages: French, Mandarin, Russian, and Spanish.
Brendan Smyth is now handing his role as lead coordinator to Michele Provenzano, and Meg Jardine will shortly replace current ISN-ACT chair, David Wheeler. The ISN greatly thanks Brendan and David for their tireless involvement in building on this initiative to expand GTF contributors and increase its circulation. We look forward to seeing the continued development of global trials under this new leadership.
The ISN is also pleased to welcome Mohamed Elrggal to the GTF team to expand its social media reach.
The curriculum is creatively designed using mixed media, including three originally produced voice-over animations, charts, graphs, and self-guided questions to engage students and facilitate learning.
The course covers the pathophysiology of renal disease along with the clinical trials guiding current management guidelines:
Definition and epidemiology of renal anemia
Pathophysiology of renal anemia
Mechanisms of erythropoiesis-stimulating agents
Trials of renal anemia
Novel and future therapies, including HIF-stabilizers
Supported by an educational grant from
Thursday , February 17, 7 p.m. CET
ISN i3C Webinar: Challenges and Opportunities for Interventions in CKDu
Nishantha Nanayakkara, Sri Lanka
Jason Glacer, USA
Brendan Smyth, Australia
Urine, Doctors, and the Acanthocyte's 30th Birthday
This editorial marks the acanthocyte's 30th birthday. In 1991, Kidney International published a foundational article naming the peculiarly shaped erythrocytes in the urine as “acanthocytes” and was the first to study systematically acanthocyturia to help diagnose glomerular disease.
The editorial presents a history of the study of urine to find a diagnosis in people with kidney diseases and the doctors who reported erythrocytes in their research.
The authors encourage hands-on microscopy of urine sediment as a fast and effective procedure to inform the choice of treatment in an emergency.
This article presents a review of the symptoms and causes of uremic encephalopathy and the difficulties associated with its diagnosis.
The authors suggest kidney replacement therapy as a possibility to improve symptoms and more research on uremic retention solutes and neurological symptoms to better understand this syndrome and develop treatments to improve cognitive function.
Implantable Loop Recorder Monitoring and the Incidence of Previously Unrecognized Atrial Fibrillation in Hemodialysis Patients
Atrial fibrillation (AF) is common in patients with kidney failure on hemodialysis. On behalf of the Monitoring in Dialysis Investigators and Committees, the authors determined its incidence in 59 patients without previously diagnosed AF.
Using implantable loop recorder monitoring, atrial fibrillation was detected in one-third of patients with kidney failure on hemodialysis.
A commentary by Law and colleagues at the University of Melbourne, Australia, discusses the clinical importance of detecting asymptomatic atrial fibrillation.